Skip to main content
Top
Published in: Abdominal Radiology 8/2019

01-08-2019 | Correction

Correction to: Imaging features of immune-mediated genitourinary disease

Authors: Jonathon D. Weber, Nancy Hammond, Vahid Yaghmai, Paul Nikolaidis, Frank H. Miller, Jeanne M. Horowitz

Published in: Abdominal Radiology | Issue 8/2019

Login to get access

Excerpt

The original version of this article was published with a error in the initials of the first, fifth and sixth author name: Jonathon Weber, Frank Miller and Jeanne Horowitz. The correct author's initials should be Jonathon D. Weber, Frank H. Miller, and Jeanne M. Horowitz. It is now corrected with this correction. …
Metadata
Title
Correction to: Imaging features of immune-mediated genitourinary disease
Authors
Jonathon D. Weber
Nancy Hammond
Vahid Yaghmai
Paul Nikolaidis
Frank H. Miller
Jeanne M. Horowitz
Publication date
01-08-2019
Publisher
Springer US
Published in
Abdominal Radiology / Issue 8/2019
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-019-02050-y

Other articles of this Issue 8/2019

Abdominal Radiology 8/2019 Go to the issue

Classics in Abdominal Radiology

A “dumbbell” vesicourethral stone

Classics in Abdominal Radiology

“Sausage” sign intussusception

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine